ClinConnect ClinConnect Logo
Search / Trial NCT04566341

Study of Gastrointestinal Dysfunction and Enteric Neural Pathology in Patients With Parkinson's Disease

Launched by MASSACHUSETTS GENERAL HOSPITAL · Sep 22, 2020

Trial Information

Current as of June 26, 2025

Enrolling by invitation

Keywords

Oct Optical Coherence Tomography Tce Tethered Capsule Endomicroscopy

ClinConnect Summary

The purpose of this study is to establish the esophageal pathology findings as imaged with tethered capsule microscopy in subjects with Parkinson Disease. Images from patients with Parkinson disease will be compared to our previously obtained images in healthy subjects to establish the spectrum of esophageal pathologies occurring in patients with Parkinson disease by OCT imaging.

In the case of imaging internal luminal organs, like the esophagus, OCT light is delivered via a long catheter. We have developed a new technique termed Tethered Capsule Endomicroscopy (TCE). TCE involves swallowi...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Idiopathic Parkinson's disease as defined by the United Kingdom PD Society Brain Bank Criteria
  • Parkinson Disease Hoehn and Yahr stage 2-4
  • Subjects on stable dose of Parkinson Disease medications for at least 4 weeks prior to the study screening
  • Subjects between 40 and 85 years old
  • Subjects who are capable of giving informed consent
  • Subjects who had no solid food for at least 4 hours prior to the procedure, and only clear liquids for 2 hours prior to the procedure
  • Exclusion Criteria:
  • Atypical or secondary Parkinson Disease
  • Esophageal fistula and/or esophageal strictures with a luminal stricture diameter that is smaller than the diameter of the capsule
  • Recent intestinal resection (within the last six months)
  • Prior gastric, esophageal or oropharyngeal surgery
  • Inability to swallow capsules
  • Pregnancy, according to patient information

About Massachusetts General Hospital

Massachusetts General Hospital (MGH) is a leading academic medical center located in Boston, Massachusetts, renowned for its commitment to advancing medical research and patient care. As a prominent teaching hospital affiliated with Harvard Medical School, MGH plays a pivotal role in clinical trials across a wide range of disciplines, including cardiology, oncology, neurology, and more. The institution is dedicated to fostering innovative research that translates into effective therapies and improved health outcomes. MGH's Clinical Trials Office provides comprehensive support to facilitate the design, implementation, and management of clinical studies, ensuring adherence to the highest ethical standards and regulatory compliance. With a focus on collaboration and patient-centered care, MGH strives to enhance medical knowledge and contribute to the future of healthcare.

Locations

Boston, Massachusetts, United States

Patients applied

0 patients applied

Trial Officials

Guillermo Tearney, M.D, PhD.

Principal Investigator

Massachusetts General Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials